Biotechnology cancer Clinical Trials

Researchers Use New AI Techniques in Clinical Trials for Personalized Cancer Treatment

Researchers are finding new ways to use artificial intelligence and nanotechnology to enhance treatments, from routine dental techniques to attacking cancerous tissue. At the AVS 65th International Symposium and Exhibition, being held Oct. 21-26, 2018, in Long Beach, California, Dean Ho will present the results of two clinical trials that show how AI-enabled personalized medical treatment for a prostate cancer patient and nanotechnology improved recovery for patients after a root
Healthcare IT News

H1 Announces Expansion of Healthcare Machine Learning Analytics Platforms

H1, a New York-based healthcare data-driven solutions provider, today announced continued growth and expansion of its global healthcare analytics platforms marked by strong top-line revenue growth. In the past year, H1 has grown from an initial team of five employees to over 150 employees globally, with international offices in New York, London, Seattle, and Hyderabad, India. With a team of over 30 data scientists and software engineers, H1 recently reported a 300% increase in top-line revenue